Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome

SAN CARLOS, Calif & SEATTLE--(BUSINESS WIRE)--Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome; Investment led by Vulcan Capital

Click to view original post